Target ICU/CKD Small medical imaging company Modulim offers the Clarifi imaging system for noninvasive microvascular assessment, with established partnerships for Limb Assessment, Management, and Preservation (LAMP) aimed at high-risk CKD and ESRD patients. Sales opportunities exist in nephrology clinics, dialysis centers, and hospital programs focused on preventing complications like diabetic foot ulcers and amputations.

Care Pathway Clarifi imaging supports early detection and intervention of microvascular dysfunction, providing clinicians with tissue oxygenation and perfusion maps. Potential upsell to care coordinators and case managers seeking cost reduction and better outcomes along the patient care continuum, from outpatient to inpatient settings.

Reimbursement Readiness Product is backed by CPT PLA code 0061U, indicating reimbursement support. This can be leveraged in conversations with hospital PPS, SSO teams, and value-based care programs to demonstrate path to insurance coverage and favorable ROI for implanting clinics and vascular teams.

Strategic Partnerships Recent and ongoing partnerships with Satellite Healthcare highlight a channel for co-selling and integrated care programs. Sales targets include health systems and ASC networks that prioritize limb preservation, vascular health programs, and CKD/ESRD patient populations.

Growth Signals Funding history and leadership with recognized experts in medical photonics, plus a clear mission to save limbs and lives, signal potential for expansion within vascular clinics, wound care centers, endocrinology practices, and telehealth-enabled vascular monitoring initiatives.